- Feb 2021
ReconfigBehSci. (2021, January 29). RT @IndependentSage: 3.7 million infected with #COVID19 in the UK. An estimated 5-10% will develop #LongCovid. We can’t afford to ignore th… [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1355097550529945607
- intensive care
- positivity rates
- neurodegenerative disease
- health crisis
- public health
- long covid
- future treatments
- Jan 2021
Naudé. W., (2020). Artificial Intelligence against COVID-19: An Early Review. Institute of Labor Economics. Retrieved from: https://covid-19.iza.org/publications/dp13110/
- Oct 2020
Omary, Areen. ‘COVID-19 Health Status Scale (CHSS)’. Preprint. PsyArXiv, 30 September 2020. https://doi.org/10.31234/osf.io/2wnxd.
- May 2019
While more traditional therapies such as chemotherapy and radiotherapy lack tumor specificity targeting all replicating cells, and other immunotherapies have limited scope by relying on the presence of a specific ligand/receptor, oncolytic viruses are postulated to be both specific to neoplastic cells and have an expansive immunostimulatory latitude. The
Chemo and Radiation lack specificity in targetting cancerous cells, instead targeting a large scope or rapidly dividing cells.
Immunotherapies are limited to the presence of ligand and receptors for activation.
Oncolytic viruses are specific to neoplastic (cancerous, specific) cells and have a large amount of immunostimulatory range----> can activate tumor immunity, stimulate immune system......
a genetically engineered or naturally occurring virus that can selectively replicate in and kill cancer cells without harming the normal tissues
Contrasting to gene therapy, where a virus is used as a mere vector (carrier of a gene), oncolytic virotherapy uses the virus as a drug agent.